Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review

Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH297367FSA
  • |
  • Pages: 37
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Hanmi Pharmaceuticals Co Ltd (128940)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company's prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counter products such as vitamins, nutritional supplements and calcium supplement, among others. Hanmi Pharma's products are used in the treatment of cancer, depression, dementia, dermatology, diabetes, anti-inflammatory, cardiovascular, epilepsy, hepatitis, hypnotics, osteoarthritis, gastrointestinal, osteoporosis and others. The company operates through its manufacturing facilities located in Hwaseong, Songpa, and Pyeongtaek, South Korea. Hanmi Pharma is headquartered in Seoul, South Korea.

Hanmi Pharmaceuticals Co Ltd Key Recent Developments

Jan 12,2017: Hanmi unveils new R&D strategy at JP Morgan Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Hanmi Pharmaceuticals Co Ltd-Key Facts 6

Hanmi Pharmaceuticals Co Ltd-Key Employees 7

Hanmi Pharmaceuticals Co Ltd-Key Employee Biographies 8

Hanmi Pharmaceuticals Co Ltd-Major Products and Services 9

Hanmi Pharmaceuticals Co Ltd-History 10

Hanmi Pharmaceuticals Co Ltd-Company Statement 12

Hanmi Pharmaceuticals Co Ltd-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Company Overview 14

Hanmi Pharmaceuticals Co Ltd-Business Description 15

Business Segment: Medicines 15

Overview 15

Performance 15

Business Segment: Overseas Drugs 15

Overview 15

Performance 15

Business Segment: Raw Drugs 15

Overview 15

Performance 15

Geographical Segment: China 16

Performance 16

Geographical Segment: Others 16

Performance 16

Geographical Segment: Republic of Korea 16

Performance 16

Geographical Segment: The US 16

Performance 16

R&D Overview 16

Hanmi Pharmaceuticals Co Ltd-SWOT Analysis 17

SWOT Analysis-Overview 17

Hanmi Pharmaceuticals Co Ltd-Strengths 17

Hanmi Pharmaceuticals Co Ltd-Weaknesses 18

Hanmi Pharmaceuticals Co Ltd-Opportunities 19

Hanmi Pharmaceuticals Co Ltd-Threats 20

Hanmi Pharmaceuticals Co Ltd-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Hanmi Pharmaceuticals Co Ltd, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Jan 12, 2017: Hanmi unveils new R&D strategy at JP Morgan Healthcare Conference 32

Section 6-Appendix 33

Methodology 33

Ratio Definitions 33

About GlobalData 37

Contact Us 37

Disclaimer 37

List of Figures

Hanmi Pharmaceuticals Co Ltd, Performance Chart (2013-2017) 26

Hanmi Pharmaceuticals Co Ltd, Ratio Charts 28

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

List of Tables

Hanmi Pharmaceuticals Co Ltd, Key Facts 6

Hanmi Pharmaceuticals Co Ltd, Key Employees 7

Hanmi Pharmaceuticals Co Ltd, Key Employee Biographies 8

Hanmi Pharmaceuticals Co Ltd, Major Products and Services 9

Hanmi Pharmaceuticals Co Ltd, History 10

Hanmi Pharmaceuticals Co Ltd, Other Locations 13

Hanmi Pharmaceuticals Co Ltd, Subsidiaries 13

Hanmi Pharmaceuticals Co Ltd, Key Competitors 21

Hanmi Pharmaceuticals Co Ltd, Ratios based on current share price 22

Hanmi Pharmaceuticals Co Ltd, Annual Ratios 23

Hanmi Pharmaceuticals Co Ltd, Annual Ratios (Cont...1) 24

Hanmi Pharmaceuticals Co Ltd, Annual Ratios (Cont...2) 25

Hanmi Pharmaceuticals Co Ltd, Interim Ratios 27

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Hanmi Pharmaceuticals Co Ltd, Recent Deals Summary 31

Currency Codes 33

Capital Market Ratios 33

Equity Ratios 34

Profitability Ratios 34

Cost Ratios 35

Liquidity Ratios 35

Leverage Ratios 36

Efficiency Ratios 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

WhanIn Pharmaceutical Co Ltd

Samjin Pharm Co Ltd

Myungmoon pharmaceutical Co Ltd

JW Holdings Corp

Ilyang Pharmaceutical Co Ltd

Daewoong Pharmaceutical Co Ltd

ChoDang Pharm Co Ltd

Hanmi Pharmaceuticals Co Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8979
Site License
USD 250 INR 17958
Corporate User License
USD 375 INR 26936

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com